Stephens Consulting’s Encompass Health EHC Stock Holding History

Stephens Consulting’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-4	Closed	-$491	–	626
2025 Q2	$491	Buy	+4	New	+$457	﹤0.01%	906

Other funds holding EHC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Stephens Consulting's EHC Position: Q3 2025 in Review

Stephens Consulting sold out of Encompass Health (EHC) in Q3 2025, closing a stake of 4 shares — an estimated $491 sold.

Stephens Consulting first reported a position in EHC in Q2 2025 and held it in 1 quarter. The position peaked at $491 in Q2 2025. 604 funds tracked by Wall St. Rank hold EHC as of Q3 2025.

Stephens Consulting reported no remaining Encompass Health position as of Q3 2025 after selling out during the quarter.
Stephens Consulting sold 4 Encompass Health shares in Q3 2025, an estimated $491.
Stephens Consulting first reported a position in Encompass Health in Q2 2025 and held it in 1 quarter.
Stephens Consulting's Encompass Health position peaked at $491 in Q2 2025.
604 funds tracked by Wall St. Rank held Encompass Health as of Q3 2025.

Based on Stephens Consulting's 13F filing for Q3 2025, filed 15 Oct 2025.